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The existence of a specialized set of skin-associated 
lymphoid tissues (SALT) was proposed several years ago 
as a means of accounting for (a) epidermotropism of 
certain malignant lymphocytes, (b) immunocompetent 
cells within skin, and (c) expression of histocompatibil-
ity a ntigens on cutaneous cells derived from hemato-
poietic precursors. The proposal was supported by ob-
servations of (a) in vivo and in vitro antigen-presenting 
potential of epidermal Langerhans cells, (b) discovery 
of novel bone marrow-derived cells within epidermis, 
and (c) epidermotropism as a physiologic property of 
some nonmalignant T lymphocytes. Langerhans cells 
stand alone among epidermal cells in their capacity to 
process and pr.esent antigens of the intraepidermal com-
partment in highly immunogenic fashion. However, not 
all antigens within epidermis lead to hypersensitivity: 
antigens introduced into Langerhans cell-deficient skin 
are perceived as tolerogens, and the cellular source of 
the tolerogenic signal may be Thy-1-positive epidermal 
cells. An extracutaneous pathway for presentation of 
epidermally-administered antigen has been described, 
and is independent of Langerhans cells, genetically de-
termined, and dominant in the face of epidermally de-
rived tolerogenic signals. Only systemic unresponsive-
ness can mitigate the cutaneous sensitivity produced by 
the second pathway. Thus, both intra- and extracuta-
neous forces contribute to the induction and regulation 
of cutaneous immunity, forces that are integrated via 
SALT to achieve optimal cutaneous immune protection 
against pathogens and neoplasms. 
rev iew, items 2, 3, and espec ially 5, which deals with the cellular 
It has been more t han 6 years since it was first proposed that 
a portion of the immune apparatus was specialized and dedi -
cated to provide the skin with immune protection [1]. The 
acronym SALT was utili zed to designate these skin -associated 
lymphoid t issues. At t hat time and during the subsequent 
several yea rs, an increasing body of circumstant ial evidence 
supports the contention that SALT exists. Evidence in favor 
of SALT includes the following: (1) some but not all lymphoid 
reticula r cells ex hibit epidermotropism; (2) epidermis contains 
cellular elements required for antigen processing, presentation, 
and recognition; (3) recognition of antigens by immunocom-
petent lymphocytes can take place wi thin skin ; (4) draining 
regional lymph nodes serve to integrate and direct cutaneous 
immune responses; and (5) regu lation of cutaneous immunity 
is dictated by elements found within skin itself (2]. In this 
This work was supported by USPHS Grant Al-17363. 
Reprint requests to: J. Wayne Streilein, M.D., Department of Mi-
crobiology and Immunology, University of Miami School of Medicine, 
RMSB (R-1 38) , P.O. Box 016960, Miami , Florida 33101. 
Abbreviations: 
CH: contact hypersensitivi ty 
EC: epidermal ce ll (s) 
LC: Langerha ns cell(s) 
MHC: Major histocompatibility complex 
SALT: sk in -associated lymphoid tissues 
TNCB: t rinitrochlorobenzene 
UVR: UV radiation 
and molecular basis of induction and regulation of cutaneous 
immunity, are explored in detail. 
EPIDERMIS CONTAINS CELLULAR ELEMENTS 
REQUIRED FOR ANTIGEN PROCESSING, 
PRESENTATION, AND RECOGNITION 
By conventional light microscopy, examination of t he skin 
and epidermis reveals that the epidermal compartment, com-
prised chiefly of epithelial cells, is contaminated by nonepi the-
lial cells, many of which are of mesenchymal origin (i.e., bone 
marrow-derived) . These cells include typical lymphocytes [3], 
the well-studied epidermal Langer hans cell (LC) [ 4,5], a novel 
population of bone marrow-derived cells [6, 7] bearing the Thy-
1 molecule (albeit Jacking in typical T -cell functional proper-
ties), and the so-called indeterminant cells. Barker and Bil-
lingham (8] demonstrated more than a decade ago that skin 
grafts contain immunocompetent lymphocytes within t hem; 
one or another of the lymphoid-appearing cells within the 
epidermis represent candidates for that role. After considerable 
study, it is apparent that epidermal LC display on their cell 
surface molecules characteris tic of cells involved in antigen 
presentation (class 2 major histocompatibility complex (MHC) 
antigens, Fe receptors for immunoglobulin , and the receptor 
for the third component of complement) [9]. In vitro studies 
indicate that LC possess the functional property of being able 
to present antigen to primed T lymphocytes [10]. Although it 
was originally and unexpectedly found that keratinocytes were 
a source of interleukin -1 (ETAF) , it is now clear that epidermal 
LC also can produce this molecule which plays a crucial role in 
antigen presentation [11,12]. 
RECOGNITION OF ANTIGEN BY 
IMMUNOCOMPETENT LYMPHOCYTES CAN TAKE 
PLACE WITHIN SKIN 
The inductive event by which immunocompetent lympho-
cytes first recognize and respond to the antigen is thought to 
take place within organized lymphoid tissues such as lymph 
nodes and spleen. That such a critical event can happen within 
the skin itself was first demonstrated by Brent and Medawar 
who inoculated allogeneic lymphocytes into the skin and dem-
onstrated that these cells were able to mount inflammatory 
reactions as a consequence of in situ recognition of alloantigens 
[13]. Indirect evidence that antigen recognition takes place 
within skin during induction of contact hypersensitivity (CH) 
was provided by the studies of Macher and Chase who demon-
strated that excision of the cutaneous site of hapten inoculation 
precluded t he development of contact hypersensitivity (14]. 
Recently by using a method of CH induction that ut ilizes 
hapten-derivatized orthotopic skin grafts (15], we demonstra-
ted that genetic elements (encoded by MHC genes) within skin 
are responsible for restricting the effector specificity of delayed-
type hypersensitivity T cells, implying that recognition by T 
cells was initiated within the skin graft. These findings provide 
support for the thesis that skin affords a microenvironment in 
which immunocompetent cells can recognize antigens. 
REGULATION OF CUTANEOUS IMMUNITY IS 
DICTATED BY ELEMENTS WITHIN SKIN 
The development of successful protocols for the induct ion of 
CH and its study in mice occurred approximately 15 years ago 
lOs 
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TABLE I. Experimental induction of contact hypersensitivity and unresponsiveness 
a. Maneuve rs to Induce Contact Hypersensitivity 
Apply epicutaneous hapte n: co nventiona l doses (TNCB 5%, DNFB 
0.5 %, Oxaza lone 10%) 
Evidence of Down Regulation 
Cyclophosphamide pretreatment 
causes enha nced response 
Immobilization of recipient leads 
to enhanced CH response 
Method to induce certain suppres-
sor T cells 
Graft hapten-derivatized skin (simi la r doses of hapten to above) 
Inject hapten s.c. 
Inject hapten-derivatized, unfractiona ted epiderma l cells i.v. 
b. Man e uvers That Induce CH Without Down Regulation 
Paint skin with t hreshold doses of haptens (10- 50 f.'g TNCB) 
Animals a re hyporesponsive to re-
immuni zation with hapten 
Gra ft syngeneic skin derivatized with limi ti ng doses of hapten (0.02 % DNFB) 
Inject hapten -derivatized, purified Lange rha ns cells i.v. or s.c. 
Inject hapten-derivat ized keratinocytes s.c. 
c. Maneuvers That Induce Down Regulation of CH 
Paint hapten on skin wi t h reduced numbers of norma l La nge rha ns cells 
Paint skin with excess hapte n 
Excise site of hapte n inoculation (within 24-48 h) 
Inject hapten-derivatized Thy-1 +epiderma l cells i.v. 
d. Maneuvers That Produce Neither Up Nor Down Regulation of CH 
Apply subthres hold doses of hapten (less t ha n 10 f.' g TNCB) to s kin 
Graft hapten-derivat ized a llogeneic skin at limi t ing dose of hapten 
Inject hapte n-derivatized keratinocytes i.v. 
Inject hapte n-derivatized Thy- 1+ epiderma l ce lls s.c. 
(16). Since that time, much has been learned about the cellular 
a nd molecular bases for t he induction and expression of CH . 
H owever, CH as a model system in mice differs in seve ra l 
important ways from the more classica l models of CH in guinea 
pigs and in man. In mice, t he doses of haptens typ ica lly used 
for CH induction are comparative ly high. Moreover, the abili ty 
of mice to disp lay CH is relatively short lived, i.e., between 2-
3 weeks after induction, mice generally prove to be refractory 
to challenge with hapten. In addition, induction of suppression 
and down regulation seems to be pa rt and parcel of every 
immunizing regimen. This has even led to the inference that 
every CH -immunizing regimen obl igatorily induces concomi-
tant down regulation. In the next section , the va lidi ty of this 
inference wi ll be explored by examining 4 questions concerning 
methods for inducing CH in mice: (1) What maneuvers regu-
larly induce CH in mice? (2) What maneuvers induce CH 
without ev idence of down regulation? (3) What maneuvers 
primari ly induce down regulat ion of CH? and (4) What maneu-
ve rs are immunologica lly null , i.e., induce neither immunogenic 
nor tolerogenic signa ls? 
MANEUVERS TOSTUDY CONTACT 
HYPERSENSITIVITY 
Evidence bearing on each of t hese questions is presented in 
Table I. (l) In Table Ia, 4 different methods for the induction 
of CH in mice are represented. The right- hand column of t he 
Table indicates that in each instance, t here is clear-cut ev idence 
in the immunized animals that down regulation and suppres-
sion have been concomitan t ly induced with CH. Cyclophospha-
mide-sensitive suppresso r ce lls are revea led when CHis induced 
in animals by the convent iona l skin pain t ing technique [17] . 
Inoculation of hapten directly s.c. is the typ ica l method ut ili zed 
to generate ce rtain types of suppresso r T cells [18,19] . Intra-
venous inoculation of haptenated epidermal cells (EC), while 
capable of inducing CH, also induces down regu lation revealed 
when subsequen t attempts to immun ize these animals by the 
conventiona l route fails [20). Thus, each of these effective 
methods of inducing CH in mice, a lso induces one or another 
form of down regulation. 
(2) By a ltering the expe rimenta l protocol, it is possible to 
produce CH in mice without any detectable signs of a down 
regulating i nfluence. Three methods described in part in our 
laboratories over the past seve ral years are listed in Table Tb. 
Significant leve ls of CH ca n be induced without evidence of 
down regulation when thre hold doses of antigen are em-
ployed- whether the induction regimen uses direct epicuta-
neous or t he artifice of derivatization of syngeneic orthotopic 
skin grafts [15]. Most important ly, purified epidermal LC, that 
have been haptenated in vitro with tri ni trophenyl (TNP) and 
a re then inoculated i.v., induce vigorous CH without down 
regulation [21 ). In these instances, animals rendered contact 
hyp ersensit ive display exaggerated responses to subsequent 
attempts to reimmunize t hem with the same hapten. 
(3) Several met hods have been devised in which suppression 
of CH dominates the animals' response to hapten challenge 
(see Table Ic). Origina lly, we desc ribed unresponsiveness as a 
consequence of painting hapten on cutaneous surfaces with 
reduced numbers of functionally normal LC [22). Claman and 
his colleagues had prev iously shown that supraopt imal doses of 
hapten painted epicutaneously lead to suppression of the im-
mune response [23). Even prior to this observation was that of 
Macher and Chase who demonstrated that premature excision 
of the site of hapten inoculation not only in terfered with the 
induction of CH, but rendered these animals specifically unable 
to respond subsequently to the contactant in question [14). 
Most recently, Sabra Sullivan (manuscript in prepa ration) has 
used purified, hapte nated Thy-1 positive EC to demonstrate 
that as few as 6000 of these cells inoculated i.v. produce specific 
and profound unresponsiveness without evidence of CH. 
(4) Yet not all experiences with hapten lead to up or down 
signals (see Table Id) . For example, doses of epicutaneously 
app lied hapten have now been ident ified which are simply below 
the threshold of immunologic recognition [24) . Sullivan et a! 
have found that 1 llg of trinit rochlorobenzene (TNCB) placed 
on the epidermis fai ls to impact t he immune system at a ll. In 
the past, we have reported t hat hapten-derivatized, orthotop i-
cally grafted, a llogeneic skin also fa ils either to sensitize or 
render unresponsive recipient mice [15]. This was t rue if t he 
amoun t of hapten applied to the allogeneic graft was at the 
threshold which allowed haptenated, syngeneic grafts to induce 
CH. Finally, Sullivan has recently shown that haptenated, 
purified keratinocytes from mouse skin , when inoculated i.v. at 
doses of 6000 per recipient, fai l to induce either sensitivity or 
unresponsiveness, although t his same number of cells injected 
s.c. induces typical CH. 
This spectrum of resul ts in which on the one hand CH 
without down regulation can be induced whi le on t he other 
hand specific (v irtually uncontaminated) unresponsiveness can 
be induced suggests that t he antigen-specific signals that 
emerge from the skin during t he induction of CH, and that lead 
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to sensitization as well as unresponsiveness, are separate and 
discrete ent it ies. To rephrase this suggestion in cellula r terms, 
we propose t hat LC a re the ep idermal source of an unambigu-
ous, immunogenic signal following haptenization of the epider-
mis. By contrast, T hy-1-positive epidermal cells are the singu-
lar source of a different signa l whose effect is the induction of 
down regulation of CH. Keratinocytes, at least in the doses in 
whic h we have examined them, are not t he source of either of 
these signals. 
CHARACTERISTICS OF EPIDERMALLY-DERIVED 
SIGNALS 
A rudimentary attempt can be made to characterize the 
Langer hans cell -derived signal, based on several lines of exper-
imental evidence: t his signal can be delivered by haptenated 
LC that are injected s.c., by hapten-derivatized syngeneic skin 
grafts, and even by hapten-derivatized grafts rendered nonvia-
ble by heating to 6o· c for 1 h [15]. However, t he signal is 
mitigated by pretreatment of t he skin painting site with UV 
radiation, and t he signal from haptenated allogeneic skin grafts 
is immunologically uninterpretable or recognizable. These data 
suggest t hat the immunogenic signal from t he epidermis con-
tains t he haptenic determinant, restricting elements of the 
H -2 complex (either class 1 or class 2 molecules), is derived 
from a UV -sensit ive source, (Langerhans cell) , but need not be 
present on a viable cell in order to be effective (Table II). 
The nature of t he down-regulating signal from t he skin is 
much less well understood (Table II) . The following character-
istics seem relevant: haptenated Thy-1 cells delivered i.v. in-
duce down regu lation, while the same cells injected s.c . produce 
no effect whatever. In addit ion, t he I-J dependent signal derived 
from the sk in (described by Granstein and Green [25]) appears 
to be insensitive to UV radiation (UVR). Bergstresser has 
demonstrated that Thy-1 -positive cells rarely survive and per-
sist in the epidermis of orthotopically-grafted skin [26]. Hap-
tenated, orthotopic syngeneic skin grafts at limit ing doses of 
hapten are unable to generate down regulation. We suspect 
therefore that the down-regu lating signal of t he epidermis 
contains the haptenic moiety, is derived from the Thy-1 + EC 
which is impervious to exposu re to UVR; the signal is recog-
nizable by components of the immune system which are located 
system ica lly (spleen) rather than locally (dra ining lymph 
nodes). 
FACTORS THAT DETERMINE SENSITIVITY OR 
UNRESPONSIVENESS 
Based on t hese fragmentary pieces of experimental evidence, 
it is possible (albeit risky) to formulate a hypothesis to account 
for the paradox that CH can be induced regularly both in t he 
laborato ry and t he clinic, yet the epidermis is a source of 
countermanding immunologic signals following epicutaneous 
app lication of hapten. This formulation considers two factors 
TABLE II. Characteristics of epidermally -deriued signals by 
contact hypersensitivity 
Immunogenic 
Hapten-specific 
MHC-restricting elements 
Derived from Langerhans 
cells 
UVR-sensitive 
Survive grafting procedure 
Tolerogenic 
Hapten -specific 
(?) 1-J restricting elements 
Derived from Thy-1 +epidermal cells 
UVR- resistant 
Dest royed during grafting procedure 
TABLE III. Immune effects of hapten-deriuatized epidermal cells are 
dependent upon route of inoculation 
Type of cell 
Langerhans cells 
Thy-1 + epiderma l cells 
Keratinocytes 
Route of inoculation 
Subcutaneous 
i 
i 
Intravenous 
i 
! 
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to be of overriding importance in determining whether, and if, 
CH or down regulation follows hapten exposure. The first is 
the dose of epicutaneously applied hapten. With respect to the 
dose response curve to TNCB described in several strains of 
mice by Sabra Sullivan, it was found that below the threshold 
of 10 J.Lg of TNCB, there was no effect upon the immune system 
[24] . In the narrow dose range above the threshold dose (10-50 
J.Lg), CH was induced without evidence of down regulation. 
However, as the dose was raised further beyond that point, in 
a strain-dependent fashion , an ever increasing component of 
down regulat ion was induced. However, at no dose, including 
the highest 14,000 J.Lg (28% TNCB in carrier) , did mice fail to 
develop detectable CH. We believe this means that at threshold 
doses of epicutaneously applied hapten , only LC are able to 
prepare a hapten-specific signal-and that signal is exclusively 
immunogenic. Higher doses of hapten appear to be required for 
Thy-1-positive EC to prepare t heir down-regulating signal. At 
even higher doses, unconjugated hapten escapes the epidermis 
and interacts directly with components of the immune system 
further upstream, producing a poorly understood array of ef-
fects. 
The second factor we feel to be of importance in determining 
whether up- or down-regulating signals dominate in CH , is the 
relationship between epidermally-derived signals, t he constit-
uents of SALT, and the interaction of SALT with the systemic 
immune apparatus. In Table III are listed the immune effects 
of the several purified populations of epidermal cells we have 
prepared, haptenated, and then inoculated by s.c. and i.v. 
routes. It was observed that LC, when haptenated, deliver an 
immunogenic signal by both routes. By contrast, Thy-1 + cells 
when hapten-derivatized and inoculated i.v. induce only down 
regulation; significantly, they make no detectable impact when 
placed s.c. Finally, keratinocytes that have been hapten -de-
rivatized a re able to immunize when injected s.c., but are 
immunologically "null" when injected i.v. We interpret these 
results to mean t hat lymph nodes draining the cutaneous site 
of hapten application are able directly to receive and t ransduce 
the Lange rhans cell-derived signal, however these same nodes 
appear to be incapable of receiving and/or transducing the 
epidermally-derived down-regulating signal. Instead, the re-
ceiver for this signal is at a more centra l site (which we presume 
to be the spleen) t hat is responsible for successful induction of 
down regulation . Since intravenously-delivered, haptenated LC 
induce CH without suppression, receivers of t his immunogenic 
epidermally-derived signal must also reside at central systemic 
(splenic) sites. 
CIRCUITS OF RECOGNITION AND REGULATION IN 
CH 
In the induction of CH and its regulation , one can construct 
hypothetical pathways or circuits by which antigen is processed, 
presented, and recognized. In Table IV, several nonmutually 
exclusive circuits are described. We believe that under normal 
circumstances, the dose of epicutaneously applied hapten dic-
tates whether CH, with or without down-regulating component, 
will take place. At the lowest, effective dose of hapten (for 
example 25 J.Lg TNCB applied epicutaneously), circuit 1 would 
apply. At higher doses, the second circuit would also be acti-
vated, thereby enlisting 2 up-regulating processes to produce 
the contact hypersensitive state. Circuit three, which is revealed 
in the artificial circumstances of our experiments, indicates 
that the LC-derived signal is a dominant one, and mediates its 
effect even when the draining lymph node is bypassed. Circuits 
4 and 5 describe the process by which epidermally prepared 
down-regulating signals, as well as i.v. delivered hapten, influ-
ence the development of CH. In both instances, the site of 
recognition of antigen, which results in the generation of 
suppression, is centrally placed, presumably in the spleen. 
Thus, since in normal circumstances epicutaneously adminis-
tered hapten reaches the draining lymph nodes prior to the 
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TABLE IV. Circuit.s for antigen recognition in contact hypersensitivity 
Form o f antige n Presen tin g cell S ite of recogniti on E ffect 
1. Free hapte n 
2. Ha pte nated ke ratinocyte 
3. Hapte nated La ngerhans 
cells 
Langerha ns cell 
In te rdigitating Cell 
In te rdigitating or 
Skin and/ or lymph node 
Lymph node 
Lymph node 
CH 
CH 
CH 
follicular dendrit-
ic cells 
4. Free hapten 
4a . Free hapten 
Thy-1+ Cell 
Thy-1+ Cell 
5. Free hapten or haptenaied 
nondendritic ce lls 
??? (In t ravenous 
presentation) 
Spleen 
Lymph node 
Splee n 
Unresponsiveness 
Unresponsiveness 
Unresponsiveness 
(4a . Proposed circui t in UVR-sen~ i tive mice) . 
cent ral compa rtment (the spleen) , the first signal produced, 
i.e. , t he immunogenic signa l derived predominantly from LC, 
dominates the early immune response, being expressed as CH . 
We have prev iously reported t hat LC of all mice a re suscep-
t ible to the deleterious effects of UVR; however, the induction 
of unresponsive ness following UVR treatment and local appli-
cation of hapten is the property of only some ge netically defin ed 
stra ins of mice 12]. We have proposed that mice who are not 
suscept ible to t he UV effect possess two pathways for t he 
effective process ing of epicutaneously applied hapten, only one 
of which is LC-dependent (and UVR-sensit ive). We presume 
t hat the a ntige n-presenting cell s of the second pathway reside 
in the dra ining regiona l lymph nodes, perhaps the interdigitat-
ing cells of circui t 2 (T able IV) . It is pertinent in t his rega rd 
t hat Glass eta!* have recently di scovered t hat suppressor cells 
a re induced in a ll stra ins of mice following hapten applicat ion 
to U VR pretreated skin , irrespective of whether t hese strains 
prove to be unresponsive in vivo or not . This findin g corrobor-
ates t he obse rvations of Granstein et a! [25] that the I-J 
dependent, epiderma lly-derived suppressor moiety is UV insen-
sitive. This raises t he possibili ty t hat the so-called second 
pathway of ant igen presentation is not missing in UV -suscep -
t ible mice. Rather, in t hese mice t he facili ty able to rece ive 
epidermally-derived down regulating signa ls may not be re-
stricted to t he spleen, but may a lso reside within draining 
regional lymph nodes (circui t 4a, Table IV) . By contrast, in 
UV -resista n t mice, t he rece ive r of down regu lating signal s is 
placed exclusive ly at t he systemic (spleen) s ite. Thus, when (by 
experimen ta l manipulation or by a clinically relevant environ-
mental effect) t he epidermis is robbed of its LC-dependent 
function , the factor which will determine whether immune 
protection is a fforded t he skin is li kely to be the genetically 
dete rmined manner in which SALT is deployed, i.e., whether 
t he rece iver for down -regulating signals is located regionally or 
cent ra lly. Al though much remains to be learned about t he 
signal s and circui ts of t hi s system, it is already possible to 
imagine how t he system could be manipulated for therapeut ic 
gain. 
* Glass M, Bergst resser PR, Ti gelaar R, a nd S t reilein JW: Prelimi-
nary observations, ma nusc ript in prepa ration. 
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